scispace - formally typeset
J

J. L. Vila-Jato

Researcher at University of Santiago de Compostela

Publications -  39
Citations -  3317

J. L. Vila-Jato is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Solubility & Drug carrier. The author has an hindex of 20, co-authored 39 publications receiving 3111 citations.

Papers
More filters
Journal ArticleDOI

Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers

TL;DR: In this paper, a new approach for the preparation of nanoparticles made solely of hydrophilic polymers is presented, based on an ionic gelation process, is extremely mild and involves the mixture of two aqueous phases at room temperature.
Journal ArticleDOI

Design of microencapsulated chitosan microspheres for colonic drug delivery.

TL;DR: New approaches for the modification of CS are presented as well as a new system with a great potential for colonic drug delivery, which combines specific biodegradability and pH-dependent release.
Journal ArticleDOI

Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A

TL;DR: In this article, the authors developed a new controlled release dosage form of administration for cyclosporin A (CyA) using poly( dl -lactide-co-glycolide) (PLGA).
Journal ArticleDOI

Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles.

TL;DR: The in‐vitro release profiles obtained using adialysis system were similar for all the nanoparticle formulations and for the control solution, indicating that drug molecules are desorbed from the nanoparticles quickly enough to maintain the equilibrium concentration in the dialysis system.
Journal Article

Development of a freeze-dried formulation of insulin-loaded chitosan nanoparticles intended for nasal administration

TL;DR: In this paper, a formule lyophilisee de nanoparticules de chitosane chargee en insuline and evaluate son efficacite dans la reduction des taux de glucose plasmatique apres administration nasale.